PTPRG and chronic myelogenous leukemia, BCR-ABL1 positive: Moreover, stratification of CML patients’ response into optimal and failed treatment groups showed that the expression level of PTPRG to be significantly higher in the optimal response group when compared to the failed group, utilizing both q-PCR and flow cytometry techniques.